What is OmniAb Inc. (OABI) stock price today?

OmniAb Inc. (OABI) currently trades at $1.36 per share. The stock has a market capitalization of $208.49M and a P/E ratio of —x.

Is OABI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, OmniAb Inc. has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is 3.64.

What is OmniAb Inc.'s revenue and earnings?

OmniAb Inc. has trailing twelve-month (TTM) revenue of $18.67M with profit margins of 0.00%. Earnings per share (EPS) is $-0.57.

Is OmniAb Inc. financially healthy?

OmniAb Inc.'s Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of 3.64 places it in the safe zone.

OABI

OmniAb Inc.

NASDAQ: OABI · HEALTHCARE · BIOTECHNOLOGY

$1.36

-2.86% today

Updated 2026-04-29

Market cap

$208.49M

P/E ratio

—

P/S ratio

11.17x

EPS (TTM)

$-0.57

Dividend yield

—

52W range

$1 – $2

Volume

0.4M

Market cap

$208.49M

P/E ratio

—

P/S ratio

11.17x

EPS (TTM)

$-0.57

Dividend yield

—

52W range

$1 – $2

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

8.5

Quality

2.5

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

3.6

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$7.33

+438.97%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 3.64 — safe zone

+ Debt/equity 0.08x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-5.68M

- Revenue declining -22.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$59.08M	$34.16M	$26.39M	$18.67M	$18.67M
Net income	$-22.33M	$-50.62M	$-62.03M	$-64.78M	$-14.18M
EPS	—	—	—	—	$-0.57
Free cash flow	$-20.75M	$703000.00	$-41.54M	$-37.02M	$-5.68M
Profit margin	-37.80%	-148.16%	-235.05%	-347.04%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
OABI	$208.49M	27	2.7	2.5	5.0	8.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

OmniAb Inc. trades at $1.36. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 3.64, it sits in the safe zone. TTM revenue stands at $18.67M.

Frequently asked questions

What is OmniAb Inc.'s stock price?

OmniAb Inc. (OABI) trades at $1.36.

Is OmniAb Inc. overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of OmniAb Inc. (OABI)?

The analyst target price is $7.33, representing +439.0% upside from the current price of $1.36.

What is OmniAb Inc.'s revenue?

TTM revenue is $18.67M.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

3.64 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.omniab.com

Quick metrics

P/S ratio11.17x

ROE-23.40%

Beta0.87

50D MA$1.67

200D MA$1.76

Shares out0.14B

Float0.10B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

OABI vs LLY →OABI vs JNJ →OABI vs ABBV →Stock screener →